March 29. 2023
Taysha Gene Therapies Inc 10-K
Taysha Gene Therapies Inc, which is in the Biological Products (No Diagnostic Substances) [2836] industry, SEC 10-K filing on March 28, 2023 had 56342 (cleaned) words - 600 were utilized for the visualizations.
Top Words:
- may - 833 instances
- product - 788 instances
- clinical - 497 instances
- company - 423 instances
- candidates - 416 instances
See the parsed data used in the visualization here.
View the actual filing on the SEC website here